Defining age partitions for thyrotropin (TSH) reference intervals in infancy: a robust statistical approach

Udara D Senarathne1, Zhong X Lu2, James C G Doery3

  • 1Department of Biochemistry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka; Department of Chemical Pathology, Monash Health Pathology, Monash Health, Melbourne, VIC, Australia; Department of Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.

Insights

Establishing age-specific thyroid-stimulating hormone (TSH) reference intervals for infants is crucial for accurate diagnosis. This study defines new TSH reference ranges for the first year of life, improving thyroid disorder detection in neonates and infants.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Chemistry
  • Neonatal Medicine

Background:

  • Thyroid hormones are vital for infant growth and neurodevelopment.
  • Accurate interpretation of thyroid-stimulating hormone (TSH) requires age-specific reference intervals (RIs), which are currently ill-defined for the first year of life.
  • Diagnostic uncertainty and unnecessary testing arise from the lack of established pediatric TSH RIs.

Purpose of the Study:

  • To establish statistically derived age partitions for TSH RIs reflecting thyroid physiology in infants up to one year old.
  • To improve diagnostic accuracy for thyroid disorders in the pediatric population.
  • To provide a reproducible method for defining age-dependent analyte partitions.

Main Methods:

  • Retrospective analysis of de-identified TSH results from 11,045 infants at a tertiary hospital.
  • Exclusion of data from infants with repeat tests, extreme TSH values, or conditions affecting thyroid function.
  • Sequential application of the Mann-Whitney U test to identify age partitions, followed by validation using Lahti et al. criteria.

Main Results:

  • Five age partitions were identified: days 0-1, 2, 3, 4-89, and 90-365.
  • TSH levels peaked on days 0-1 (RI: 1.9-40.1 mIU/L), decreased sharply by day 2, and reached near-adult levels by days 90-365 (RI: 0.7-5.7 mIU/L).
  • No significant sex-based differences in TSH levels were observed.

Conclusions:

  • A robust, data-driven framework for age-specific TSH RIs in infants aged 0-365 days has been established.
  • The defined TSH RIs enhance diagnostic accuracy for infant thyroid disorders.
  • The methodology offers a reproducible approach for defining age-specific reference intervals for other analytes.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
5.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
403
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
11
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
15
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
543